Page last updated: 2024-11-07

ro 43-5054

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Ro 43-5054: structure given in first source; low molecular weight, noncyclic, peptidomimetic inhibitor [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID132121
CHEMBL ID138429
SCHEMBL ID7299599
MeSH IDM0209628

Synonyms (17)

Synonym
138107-58-1
n-(n-(n-(p-amidinobenzoyl)-beta-alanyl)-l-alpha-aspartyl)-3-phenyl-l-alanine
l-phenylalanine, n-(n-(n-(4-(aminoiminomethyl)benzoyl)-beta-alanyl)-l-alpha-aspartyl)-
ro 43-5054
p-amidinobenzoyl-beta-alanyl-aspartyl-phenylalanine
ro 435054
CHEMBL138429
SCHEMBL7299599
DTXSID50160466
n-(4-carbamimidoylbenzoyl)-beta-alanyl-l-alpha-aspartyl-l-phenylalanine
5yb ,
ro-435054
(s)-3-(3-(4-carbamimidoylbenzamido)propanamido)-4-(((s)-1-carboxy-2-phenylethyl)amino)-4-oxobutanoic acid
Q27456123
(3s)-3-[3-[(4-carbamimidoylbenzoyl)amino]propanoylamino]-4-[[(1s)-1-carboxy-2-phenylethyl]amino]-4-oxobutanoic acid
PD161581
AKOS040747408
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID73164Inhibition of fibrinogen binding to immobilized fibrinogen receptor1992Journal of medicinal chemistry, Nov-13, Volume: 35, Issue:23
Low molecular weight, non-peptide fibrinogen receptor antagonists.
AID223375Inhibition of platelet aggregation in human-platelet rich plasma(h-PRP) induced by adenosine 5'-diphosphate-(ADP)1992Journal of medicinal chemistry, Nov-13, Volume: 35, Issue:23
Low molecular weight, non-peptide fibrinogen receptor antagonists.
AID217303Inhibition of fibrinogen binding to immobilized vitronectin receptor1992Journal of medicinal chemistry, Nov-13, Volume: 35, Issue:23
Low molecular weight, non-peptide fibrinogen receptor antagonists.
AID223376Inhibition of platelet aggregation in human-platelet rich plasma(h-PRP) induced by collagen1992Journal of medicinal chemistry, Nov-13, Volume: 35, Issue:23
Low molecular weight, non-peptide fibrinogen receptor antagonists.
AID223377Inhibition of platelet aggregation in human-platelet rich plasma(h-PRP) induced by thrombin1992Journal of medicinal chemistry, Nov-13, Volume: 35, Issue:23
Low molecular weight, non-peptide fibrinogen receptor antagonists.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's7 (87.50)18.2507
2000's1 (12.50)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.87

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.87 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.17 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.87)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]